September 9, 2008 - CoreValve said today five clinical evaluation sites (two in New Zealand and three in Australia) have now completed their first series of proctored cases using the company’s...
August 28, 2008 - CoreValve said today an Australia/New Zealand-focused clinical evaluation of its proprietary percutaneous ReValving System, which features a porcine pericardium valve mounted in...
April 22, 2008 - A new type of medication based on raising high-density lipoproteins (HDL), can lead to an improvement in the aortic valve narrowing, reported study results published on-line in...
April 14, 2008 - ESTECH will showcase its new CG LiV Kits, designed to enable mitral and aortic valve procedures, at the American Association for Thoracic Surgery 88th Annual Meeting in San Diego...
March 5, 2008 - Edwards Lifesciences Corp. reported that the first three human implants of the next-generation Edwards transcatheter aortic heart valve were performed at St. Paul's Hospital in...
February 8, 2008 - CryoLife Inc. received 510(k) clearance from the FDA for its CryoValve SG pulmonary human heart valve processed with the company’s proprietary SynerGraft technology, providing a...
December 18, 2007 - ATS Medical Inc. today announced it has received FDA clearance for the ATS Open Pivot AP360 Mechanical Heart Valve designed to maximize hemodynamic performance with a new supra...
December 11, 2007 - ValveXchange, developer of a next-generation replacement heart valve technology, won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 Conference...
June 20, 2007 —Robotic surgical technology available at Cedars-Sinai Medical Center avoids long-term use of blood thinners and problems such as infection by repairing the mitral valve instead of...
May 15, 2007 — Edwards Lifesciences Corp. announced last week that its subsidiary, Edwards Lifesciences PVT, Inc., has filed a patent infringement lawsuit against CoreValve Inc., of Irvine, Calif...
April 18, 2007 — Associated Press reports that on Tuesday U.S. marshals and FDA investigators began seizing heart valves and other implantable medical devices made from cow and pig tissue by a New...
March 22, 2007 — Evalve, Inc., a privately held medical device company, has announced the FDA has approved a registry of up to 70 patients who are at high risk of mortality from surgical treatment...
CoreValve announced that its patented ReValving System, consisting of a 18F delivery catheter, was used to percutaneously implant its proprietary porcine pericardial-tissue bioprosthesis over the...
A test designed to measure the durability of CoreValve’s ReValving device reached 200 million cycles, the company has reported. CoreValve’s chairman, CEO and founder, Dr. Jacques Seguin, says...
A new procedure that delivers and places or repairs a heart valve through a catheter could soon become an alternative to open heart surgery for extremely high-risk patients.
